all patients | male | female | ||
---|---|---|---|---|
N | 101 | 41 | 60 | P value |
Age [years] (range) | 57 (21-83) | 58 (24-79) | 56 (21-83) | 0.314 |
ASA score (range) | 2 (1-3) | 2 (1-3) | 2 (1-3) | 0.904 |
Height [cm] (range) | 170 (151-194) | 177 (163-194) | 165 (151-182) | < 0.001 |
Weight [kg] (range) | 78 (47-125) | 84 (64-125) | 73 (47-120) | < 0.001 |
BMI [kg/m2] (range) | 26.83 (19.02-43.55) | 27.09 (20.66-39.18) | 26.66 (19.02-43.55) | 0.131 |
BSA [m2] (range) | 1.73 (1.37-2.19) | 1.88 (1.64-2.19) | 1.63 (1.37-1.93) | < 0.001 |
PBW [kg] (range) | 63.2 (44.23-87.67) | 72 (59.6-87.67) | 57.2 (44.23-72.3) | 0.195 |
Tumor entities | ||||
Glioblastoma | 15 | |||
Astrocytoma | 11 | |||
Neurinoma | 6 | |||
Meningeoma | 27 | |||
Angioma | 7 | |||
Metastasis | 16 | |||
Pituitary | 7 | |||
Other | 12 | |||
Preoperative comorbidities | ||||
Hypertension (%) | 31 (30.7) | 12 (29.3) | 19 (31.8) | 0.991 |
Myocardial infarction (%) | 3 (3.0) | 3 (7.3) | 0 | 0.063 |
Stroke (%) | 3 (3.0) | 3 (7.3) | 0 | 0.063 |
Adipositas (%) | 11 (10.9) | 4 (9.8) | 7 (11.8) | 1 |
Current smoker (%) | 13 (12.9) | 7 (17.1) | 6 (10) | 0.312 |
Preoperative medication | ||||
ACE inhibitors (%) | 19 (18.8) | 8 (19.5) | 11 (18.3) | 0.927 |
β-blockers (%) | 18 (17.8) | 8 (19.5) | 10 (16.7) | 0.904 |
Proton pump inhibitors (%) | 28 (27.7) | 11 (26.8) | 17 (28.3) | 0.932 |
Anticonvulsives (%) | 19 (18.8) | 6 (14.6) | 13 (21.7) | 0.541 |
Diuretics (%) | 14 (13.8) | 6 (14.6) | 8 (13.3) | 0.927 |
Calcium antagonist (%) | 7 (7.0) | 5 (12.2) | 2 (3.3) | 0.115 |
Steroids (%) | 37 (36.6) | 18 (43.9) | 19 (31.7) | 0.280 |
Statins (%) | 5 (5.0) | 3 (7.3) | 2 (3.3) | 0.391 |